BioCentury
ARTICLE | Company News

Institut Pasteur, Stragen Healthcare Group deal

July 13, 2015 7:00 AM UTC

Institut Pasteur granted Stragen’s Stragen Pharma S.A. unit exclusive, worldwide rights to STR-324 and IP covering derivatives of endogenous dual enkephalinase inhibitors to treat pain. The compound a...